Relmada Therapeutics Inc (RLMD)

Jul 27, 2026

Relmada Therapeutics Inc (RLMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

Relmada Therapeutics Inc (RLMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

RLMD|Relmada Therapeutics Inc|Price:5.180|Chg%:-0.020 - TradingKey

Jul 27, 2026

Jul 26, 2026

Relmada Therapeutics Inc Revenue Breakdown – FWB:4E2 - TradingView

Jul 26, 2026

Jul 25, 2026

Relmada Therapeutics Inc (RLMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

Relmada Therapeutics Inc (RLMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 25, 2026

Jul 24, 2026

Relmada Therapeutics Inc (RLMD) Institutional Confidence - TradingKey

Jul 24, 2026

Jul 16, 2026

Relmada Therapeutics schedules Q2 2026 financial results call - Bitget

Jul 16, 2026

Jul 16, 2026

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Investing News Network

Jul 16, 2026

Jul 16, 2026

Relmada Therapeutics to announce Q2 2026 financial results - scanx.trade

Jul 16, 2026

Jul 14, 2026

Mizuho Securities Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $19 - Moomoo

Jul 14, 2026

Jul 10, 2026

RELMADA THERAPEUTICS INC (RLMD) Stock Chart - ChartMill

Jul 10, 2026

Jul 10, 2026

Relmada Therapeutics (RLMD) Short Interest & Short Float | Updated Jul 2026 - MarketBeat

Jul 10, 2026

Jul 09, 2026

Relmada Therapeutics Inc. (RLMD) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 09, 2026

Jul 07, 2026

Relmada's cancer drug candidate sparks fresh bullish call - MSN

Jul 07, 2026

Jul 04, 2026

RLMDRelmada Therapeutics Inc Options - Finviz

Jul 04, 2026

Jul 03, 2026

Relmada Therapeutics (RLMD) Faces Minor Pullback, Testing Key Support LevelsAAII Bullish - dars.gov.et

Jul 03, 2026

Jul 03, 2026

RLMD Q1 2026 Earnings: Reported Loss Exceeds Expectations, Stock DropsDiluted EPS Report - DonanımHaber

Jul 03, 2026

Jun 30, 2026

Enterprise value to EBITDA forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView

Jun 30, 2026

Jun 30, 2026

Enterprise value to revenue forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView

Jun 30, 2026

Jun 30, 2026

Price to book forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView

Jun 30, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics added to Russell 2000 and 3000 indexes - Investing.com

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com Australia

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics (RLMD) Joins Russell 2000 and 3000 Indices - GuruFocus

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Price to earnings forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Price to sales forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView

Jun 29, 2026

Jun 29, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

RLMD Jumps As HC Wainwright Launches Buy Coverage - timothysykes.com

Jun 26, 2026

Jun 26, 2026

RLMD Jumps As H.C. Wainwright Launches Bullish Coverage - timothysykes.com

Jun 26, 2026

Jun 26, 2026

Relmada Therapeutics Inc Actuals & Estimates (NASDAQ:RLMD) - TradingView

Jun 26, 2026

Jun 26, 2026

RLMD Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

4E2 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

RLMD Q1 2026 Earnings: EPS Miss as Stock Edges Higher on Pipeline FocusEPS Estimate Trend - dars.gov.et

Jun 24, 2026

Jun 23, 2026

Relmada Therapeutics Inc (NASDAQ: RLMD) Share Price, RLMD Stock News, RLMD Share Price & Updates - Kalkine

Jun 23, 2026

Jun 23, 2026

Relmada Therapeutics stock maintained at Buy by H.C. Wainwright - Investing.com

Jun 23, 2026

Jun 23, 2026

H.C. Wainwright Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Jun 23, 2026

Jun 23, 2026

H.C. Wainwright Reiterates Buy Rating on Relmada Therapeutics Inc (RLMD) - StreetInsider

Jun 23, 2026

Jun 23, 2026

Form 13G Relmada Therapeutics For: 22 June By Investing.com - Investing.com Australia

Jun 23, 2026

Jun 22, 2026

Millennium Group reports 4.57M Relmada shares (NASDAQ: RLMD) in 13G - Stock Titan

Jun 22, 2026

Jun 21, 2026

Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com

Jun 21, 2026